[METAvivor](https://www.metavivor.org)

March 2026 (Letter of Intent) | August 2026 (Full application, invited only)

Up to $450,000 total over three years per award; typically supports established investigators.

Supports innovative research projects addressing key barriers in metastatic breast cancer (MBC) through basic, translational, or clinical studies.

--- ## Description The METAvivor Translational Research Award is designed to advance discovery and early-phase research that addresses critical problems in metastatic breast cancer (MBC). This grant supports established investigators aiming to improve mechanistic understanding, diagnosis, or treatment of MBC. Projects may span basic, translational, or clinical research, with an emphasis on innovative approaches that could significantly impact the field. The goal is to drive progress toward transforming MBC from a terminal disease to a manageable chronic condition. --- ## Due Dates - March 2026: Letter of Intent (anticipated/projected) - August 2026: Full application deadline for invited applicants (anticipated/projected) *All dates are projected based on the annual cycle; check the program page for updates.* --- ## Funding Amount - Up to $450,000 total per award, distributed over three years. - Funding supports direct research costs; the number of awards may vary based on available funds. --- ## Eligibility - Applicants must hold a clinical or research doctoral degree (e.g., MD, PhD, or equivalent). - Open to established investigators actively engaged in metastatic breast cancer research. - Research must directly address the mechanistic understanding, diagnosis, or treatment of metastatic breast cancer. - Both U.S. citizens and non-citizen U.S. nationals conducting research in the United States are eligible. --- ## Application Process - The process begins with submission of a Letter of Intent (LOI) by the anticipated March deadline. - LOIs are peer- and advocate-reviewed for scientific merit and potential patient impact. - Only top-scoring LOI applicants are invited to submit a full application (anticipated deadline in August). - Full applications undergo further review by scientific experts and patient advocates, with final funding decisions made by the METAvivor Board of Directors. - Application materials and detailed instructions are available via the [METAvivor grant portal](https://metavivor.infoready4.com/#homePage). --- ## Additional Information - The award is highly competitive and seeks projects with the potential to catalyze larger-scale funding or translate findings into new therapies. - The program emphasizes collaboration between researchers and patient advocates throughout the review process. - Announcements regarding the next grant cycle typically appear in late January. --- ## External Links - [METAvivor Grant Application Portal](https://metavivor.infoready4.com/#homePage) - [METAvivor Grant Program Overview](https://www.metavivor.org/research/grant-program/) - [Apply for a METAvivor Grant](https://www.metavivor.org/research/apply-for-a-grant/) - [Our Grant Process](https://metavivor.org/research/our-grant-process/) --- ## Contact Information | Contact Type | Details | |----------------------|----------------------------------------------------------------------------------------| | General Inquiries | [info@metavivor.org](mailto:info@metavivor.org) | | Contact Form | [METAvivor Contact Page](https://www.metavivor.org/about-us/contact-us/) |

METAvivor Translational Research Award

Sign in to see full grant listing